Risk of PSC Reduced 86% in IBD Patients Who Receive Statin Therapy

[Scipio]

Huge decrease of risk of developing Primary Sclerosing Cholangitis (a serious disease of the bile ducts that can lead to liver failure) is associated with statin use in IBD patients:

In IBD Patients, Statin Use Associated with Lower Risk of Developing PSC | GI and Hepatology News (mdedge.com)